Navigation Links
Study links vitamin D to colon cancer survival
Date:6/18/2008

BOSTON--Patients diagnosed with colon cancer who had abundant vitamin D in their blood were less likely to die during a follow-up period than those who were deficient in the vitamin, according to a new study by scientists at Dana-Farber Cancer Institute.

The findings of the study -- the first to examine the effect of vitamin D among colorectal cancer patients -- merit further research, but it is too early to recommend supplements as a part of treatment, say the investigators from Dana-Farber and the Harvard School of Public Health.

In a report in the June 20 issue of the Journal of Clinical Oncology, the authors note that previous research has shown that higher levels of vitamin D reduce the risk of developing colon and rectal cancer by about 50 percent, but the effect on outcomes wasn't known. To examine this question, the investigators, led by Kimmie Ng, MD, MPH, and Charles Fuchs, MD, MPH, of Dana-Farber, analyzed data from two long-running epidemiologic studies whose participants gave blood samples and whose health has been monitored for many years.

They identified 304 participants in the Nurses' Health Study and the Health Professionals Followup Study who were diagnosed with colorectal cancer between 1991 and 2002. All had had vitamin D levels measured in blood samples given at least two year prior to their diagnosis. Each patient's vitamin D measurement was ranked by "quartiles" -- the top 25 percent, the next lowest 25 percent, and so on. Those whose levels were in the lowest quartile were considered deficient in vitamin D.

The researchers followed the 304 patients until they died or until 2005, whichever occurred first. During that period, 123 patients died, with 96 of them dying from colon or rectal cancer. The researchers then looked for associations between the patients' previously measured vitamin D blood levels and whether they had died or survived.

The results showed that individuals with the vitamin D levels in the highest quartile were 48 percent less likely to die (from any cause, including colon cancer) than those with the lowest vitamin D measurements. The odds of dying from colon cancer specifically were 39 percent lower, the scientists found.

"Our data suggest that higher prediagnosis plasma levels of [vitamin D] after a diagnosis of colorectal cancer may significantly improve overall survival," the authors wrote. "Future trials should examine the role of vitamin D supplementation in patients with colorectal cancer."

The measurements of vitamin D in the patients' blood reflected both the amounts made by the body when exposed to sunlight and to all sources of the vitamin in their diets, said Ng. However, she added, there may be additional unknown factors that might account for individual differences. Patients with the highest vitamin D levels tended to have lower body-mass index (BMI) indicating that they were leaner, and also were more physically active. However, after controlling for BMI and physical activity, as well as other prognostic factors, higher vitamin D levels were still independently associated with better survival rates.

Ng said that a trial is being planned in which colon cancer patients will take vitamin D along with post-surgery chemotherapy to look for any benefits of the supplements.

Meanwhile, she said that individuals with colon cancer should consult their physicians as to whether they should add vitamin supplements to their daily regimen. Standard recommended daily amounts of vitamin D supplements range from 200 International Units (IU) per day for people under age 50 to 400 IU for people between 50 and 70, and 600 IU for those over 70.


'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert

Related medicine news :

1. Study: Medicare Competitive Bidding Program Could Impede Seniors Access to Diabetes Testing Supplies
2. Study finds Childrens Hospital patient safety program improves caregiver/family communications
3. Study Shows Mothers Who Take Chlorella Boost Babies Antibodies During Breast Feeding
4. Sprinters closest to starter pistol have advantage over those farther away, says study
5. Study indicates grape seed extract may reduce cognitive decline associated with Alzheimers disease
6. Study Ties Herpes Virus to Emerging Form of Diabetes
7. Study underway to find an alternative cure for Crohns disease and ulcerative colitis
8. New study shows American Cancer Society program helps employers
9. New study shows potential to treat or prevent viral cancers
10. Harvard Study in Joint Commission Journal: Mortality Rates Lower in Leapfrog Hospitals
11. Emory study of syphilis bacteria yields valuable diagnostic tool
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Early this week, Team Iconic ... awareness of Nestlé KITKAT as the first global confectionery brand sourced from 100% sustainable ... and the quality of their product, through activities that focus on better farming, better ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... care communications company offering education, research and medical media, has launched ... working in infectious diseases. , As the all-inclusive resource for infectious disease ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... its revolutionary new 2.0 version at the International Roofing Expo in Orlando, Florida ... of the world's most advanced weather technology in the hands of consumers, roofing ...
(Date:2/10/2016)... ... February 10, 2016 , ... InDemand Interpreting ... Healthcare, recently partnered with Heart City Health Center to improve access ... years, Heart City Health Center has provided the Elkhart community with access to ...
(Date:2/10/2016)... ... February 10, 2016 , ... Compliancy Group LLC ... of medical professionals throughout the country. The Guard was specifically designed to handle ... procedures, employee training, regulatory updates, and compliance coaching. , In addition to meeting ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 2016  Oxis International Inc. (OTC/QB: OXIS) announced today ... as a "clinical trial triumph" after one of the ... cancer remission. Daniel Vallera , a ... Center. --> Daniel Vallera , a ... Center. --> An article on the ...
(Date:2/10/2016)... Association, in partnership with ALS Finding a Cure, is pleased ... track TDP43 aggregation. The successful team(s) with the most developed ... --> --> ALS is ... brain and the spinal cord. Eventually, people with ALS lose ... leads to total paralysis and death within two to five ...
(Date:2/10/2016)... LONDON , February 10, 2016 ... --> Puerto Rico Healthcare and Life Sciences Report ... new 61 page Puerto Rico Healthcare and Life Sciences ... sciences insights into the fifth largest territory in the world ... R&D, medical device and diagnostics manufacturing, and more universities per ...
Breaking Medicine Technology: